Limited resources countries (5)
Developing countries (4)
Device-associated infection (4)
Hospital infection (4)
Network (4)
COVID-19 (3)
HIV (3)
Nosocomial infection (3)
Antibiotic resistance (2)
Antiretroviral therapy (2)
Health care-associated infection (2)
Hepatitis B (2)
Low income countries (2)
Low-income countries (2)
Mortality (2)
Risk factor (2)
Ventilator-associated pneumonia (2)
  (1)
19 (1)
Antibody (1)
antiretroviral therapy (1)
Antiviral agents (1)
Aspartate aminotransferase-to-platelet ratio index (1)
Autoimmune systemic rheumatic diseases (1)
Bloodstream infection (1)
Bloodstream infections (1)
Bone mineral density (1)
Catheter-associated urinary tract infection (1)
Central line-associated bloodstream infections (1)
Chlorhexidine-impregnated catheters (1)
Chronic Hepatitis B (1)
cohort (1)
comorbidities (1)
COVİ (1)
Critical care (1)
D‐ (1)
disease course (1)
favipiravir (1)
fibrosis-4 (1)
Health-care associated infections (1)
Healthcare-associated infection (1)
hepatitis B (1)
Hospital Nosocomial infections (1)
human immunodeficiency virus (1)
Immunoprophylaxis (1)
Impregnated catheters (1)
Insulin resistance (1)
Intensive care unit (1)
Intensive care Worldwide (1)
IPSS (1)
Lifestyle Habits (1)
Lipid profile (1)
Lipids (1)
lopinavir (1)
Loss of HBsAg (1)
LUTS (1)
metabolic effect (1)
Metabolic effects (1)
Middle East (1)
Middle-income countries (1)
Mixed-effects model (1)
Multiple Logistic Regression (1)
Nosocomial infections Intensive care unit (1)
observational study (1)
optic neuritis (1)
Pandemic (1)
prognostic factors (1)
Renal function (1)
Risk factor Hospital infections (1)
Seroconversion (1)
Systemic inflammatory response index (1)
Tenofovir alafenamide (1)
Tenofovir disoproxil fumarate (1)
triglyceride glucose index (1)
urinary tract (1)
Urinary tract infection (1)
Vaccination (1)
Vertical Transmission (1)
Weight Gain (1)
Weight Loss (1)